A Meta-analysis of the Severity of Acute Pancreatitis (AP) in COVID-19 Infection.
Other Scholarly Work
Aziz, Ahmed Ali, Aziz, Muhammad Ali, Omar, Nosheen et al. (2023). A Meta-analysis of the Severity of Acute Pancreatitis (AP) in COVID-19 Infection.
. CUREUS, 15(5), e38764. 10.7759/cureus.38764
Aziz, Ahmed Ali, Aziz, Muhammad Ali, Omar, Nosheen et al. (2023). A Meta-analysis of the Severity of Acute Pancreatitis (AP) in COVID-19 Infection.
. CUREUS, 15(5), e38764. 10.7759/cureus.38764
Many studies have reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affecting the gastrointestinal tract and causing gastritis, colitis, duodenitis and acute pancreatitis (AP). We conducted a meta-analysis to evaluate if SARS-CoV-2 infection (COVID-19 infection) affects the outcomes and severity of AP. We searched for articles in PubMed (MEDLINE), Cochrane Library, and clinicaltrials.gov databases and included studies comparing the outcomes of AP in patients with and without COVID-19. Our outcomes were the mean age of occurrence of AP, Charlson Comorbidity Index, incidence of idiopathic etiology of AP, severity of AP, incidence of necrotizing pancreatitis, need for intensive care unit (ICU) admission, and mortality between the two cohorts. We included five observational studies with a total population of 2,446 patients. Our results showed that in COVID-19 patients; AP had higher odds of having an idiopathic etiology (odds ratio, OR 3.14, 95% confidence interval, CI 1.36-7.27), be more severe (OR 3.26, 95% CI 1.47-7.49), had higher risk for pancreatic necrosis (OR 2.40, 95% CI 1.62-3.55), require ICU admission (OR 4.28, 95% CI 2.88-6.37) and had higher mortality (OR 5.75, 95% CI 3.62-9.14) than in patients without COVID-19 infection. Our study concluded that SARS-CoV-2 infection does increase the morbidity and mortality associated with AP and further large-scale multi-center studies are needed to confirm these results.
